Abstract
Background: The study evaluated the impact of interferences on the analytical specificity of three commercial and commonly used creatinine methods (two Jaffe and one enzymatic).
Methods: Manufacturer creatinine methods plus modified methods were tested with the following interferences: spiking serum with bilirubin, albumin, glucose, hemoglobin and lipid, and patient sera with maximum concentrations of bilirubin, 1,090 µmol/l and protein, 117.8 g/l.
Results: Hemoglobin, 7.5 g/l and lipaemic with triglyceride concentration of 6.27 mmol/l, did not interfere with all assays. Glucose >33.3 mmol/l increased creatinine recovery for Dimension method. Samples spiked with bilirubin imparted a negative bias for Dimension and Architect methods but imparted a positive bias for Vitros assay. However, using patient sera, negative bias with bilirubin was found for all methods, from which Architect method gave the highest effect (R 2=0.861), followed by Vitros (R 2=0.239) and Dimension (R 2=0.163). Protein provided the positive bias for all creatinine measurements that increased with increasing concentration (R 2 ranging from 0.104 to 0.182, P<0.0001). Addition of sodium dodecyl sulfate (SDS) in alkaline‐picrate reagent reduced the effect of bilirubin and protein for kinetic Jaffe method. Although adding potassium ferricyanide was well effective for eliminating negative interference of bilirubin, it was prone to interference from protein.
Conclusions: Endogenous interferences continue to plague creatinine accuracy measurement in both Jaffe and enzymatic methods, and consequentially the estimated glomerular filtration rate. The addition of SDS to the alkaline‐pirate reagent was shown to be effective in reducing bilirubin and protein interferences. J. Clin. Lab. Anal. 24:123–133, 2010. © 2009 Wiley‐Liss, Inc.
Keywords: kinetic Jaffe method, enzymatic method, analytical performance, commercial, glomerular filtration rate
REFERENCES
- 1. National Kidney Foundation . K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;39:S1–266. [PubMed] [Google Scholar]
- 2. Stevens LA, Levey AS. Chronic kidney disease in the elderly. How to assess risk? [Editorial]. N Engl J Med 2005;352:2122–2124. [DOI] [PubMed] [Google Scholar]
- 3. Levey AS, Bosch JP, Lewis JB, Green T, Rogers N, Roth D. A more accurate method to predict glomerular filtration rate from serum creatinine: A new prediction equation. Ann Int Med 1999;130:461–470. [DOI] [PubMed] [Google Scholar]
- 4. Cockcroft Dw, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41. [DOI] [PubMed] [Google Scholar]
- 5. Walser M, Drew HH, Guldan JL. Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. Kidney Int 1993;44:1145–1148. [DOI] [PubMed] [Google Scholar]
- 6. Myers GL, Miller WG, Coresh J, et al. Recommendation for improving serum creatinine measurement: A report from Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006;52:5–18. [DOI] [PubMed] [Google Scholar]
- 7. Joint Specialty Committee for Referal Association . Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral. Royal College of Physicians of London: London, Available at: http://www.renal.org/CKDguide/full/UKCKD‐full.pdf (accessed 21 Nov 2005). [DOI] [PubMed] [Google Scholar]
- 8. The Australasian Creatinine Consensus Working Group . Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: A position statement. Med J Aust 2005;183:138–141. [DOI] [PubMed] [Google Scholar]
- 9. Jaffe M. Uber den niederschlag, welchen pikrinsaure in normalen hrn erzeugt und uber eine neue reaction des kreatinins. Z Physiol Chem 1886;10:391–400. [Google Scholar]
- 10. Lindback B, Bergman A. A new commercial method for the enzymatic determination of creatinine in serum and urine evaluated: Comparison with a kinetic Jaffe method and isotope dilution mass spectrometry. Clin Chem 1989;35:835–837. [PubMed] [Google Scholar]
- 11. Tanganelli E, Prencipe L, Bassi D, Cambiaghi S, Murador E. Enzymic assay of creatinine in serum and urine with creatinine iminohydrolase and glutamate dehydrogenase. Clin Chem 1982;28:1461–1464. [PubMed] [Google Scholar]
- 12. Knapp ML, Hadid O. Investigations into negative interference by jaundiced plasma in kinetic Jaffe methods for plasma creatinine determination. Ann Clin Biochem 1987;24:85–97. [DOI] [PubMed] [Google Scholar]
- 13. Datta P, Graham GA, Schoen. Interference by IgG paraproteins in the Jaffe method for creatinine determination. Am J Clin Pathol 1986;85:463–468. [DOI] [PubMed] [Google Scholar]
- 14. Blank Dw, Nanji AA. Ketone interference in estimation of urinary creatinine; Effect on creatinine clearance in diabetic ketoacidosis. Clin Biochem 1982;15:279–280. [DOI] [PubMed] [Google Scholar]
- 15. Cholongitas E, Marelli L, Kerry A, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Traspl 2007;13:523–529. [DOI] [PubMed] [Google Scholar]
- 16. Lolekha PH, Jaruthunyaluck S, Srisawasdi P. Deproteinization of serum: Another best approach to eliminate all from of bilirubin interference on serum creatinine by the kinetic Jaffe reaction. J Clin Lab Anals 2001;15:116–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Bowers LD, Wong ET. Kinetic serum creatinine assays. II. A critical evaluation and review. Clin Chem 1980;26:555–561. [PubMed] [Google Scholar]
- 18. Lolekha PH, Sritong N. Comparison of techniques for minimizing interference of bilirubin on serum creatinine determined by the kinetic Jaffe reaction. J Clin Lab Anals 1994;8:391–399. [DOI] [PubMed] [Google Scholar]
- 19. O'Leary N, Pembroke A, Duggen PF. A simplified procedure for eliminating the negative interference of bilirubin in the Jaffe reaction for creatinine. Clin Chem 1992;38:1749–1751. [PubMed] [Google Scholar]
- 20. Boot S, LaRoche N, Legg EF. Elimination of bilirubin interference in creatinine assays by routine techniques: Comparisons with a high performance liquid chromatography method. Ann Clin Biochem 1994;31:262–266. [DOI] [PubMed] [Google Scholar]
- 21. Dimeski G, McWhinney B, Jones B, Mason R, Carter A. Extent of bilirubin interference with Beckman creatinine methods. Ann Clin Biochem 2008;45:91–92. [DOI] [PubMed] [Google Scholar]
- 22. Junge W, Wilke B, Halabi A, Klein G. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffe method. Clin Chem Acta 2004;344:137–148. [DOI] [PubMed] [Google Scholar]
- 23. Owen LJ, Keevil BG. Does bilirubin cause interference in Roche Creatinine Method? Clin Chem 2007;53:370–371. [DOI] [PubMed] [Google Scholar]
- 24.National Committee for Clinical Laboratory Standards: Interference Testing in Clinical Chemistry, Approved Guideline. Document EP7‐A. Wayne, Pa, NCCLS 2002.
- 25. Glick JH, Brown DM, Crocker CL, Halsten SM, Peine CA. Preparation of reagents for use with the Beckman Astre‐8. Clin Chem 1980;26:358–359. [PubMed] [Google Scholar]
- 26. Vickery S, Stevens PE, Dalton RN, Lente FV, Lamb EJ. Does the ID‐MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays. Nephrol Dial Transplant 2006;21:2439–2445. [DOI] [PubMed] [Google Scholar]
- 27. Peake M, Whiting M. Measurement of serum creatinine‐current status and future goals. Clin Biochem Rev 2006;27:173–184. [PMC free article] [PubMed] [Google Scholar]
- 28. Parry DM. Use of single‐value protein compensation of the Jaffe creatinine assay contributes to clinically significant inaccuracy in results. Clin Chem 2008;54:215–216. [DOI] [PubMed] [Google Scholar]
- 29. Kroll MH, Ruddel ME, Blank DW, Elin RJ. A model for the assessment of interference. Clin Chem 1987;33:1121–1123. [PubMed] [Google Scholar]
- 30. Wiesner R, Edwards E, Freeman R. Model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–96. [DOI] [PubMed] [Google Scholar]